Erratum: Expression of Concern: Lichen Secondary Metabolites in Flavocetraria cucullata Exhibit Anti-Cancer Effects on Human Cancer Cells through the Induction of Apoptosis and Suppression of Tumorigenic Potentials (PLoS ONE 9: 10 (e111575) DOI: 10.1371/journal.pone.0111575);Lichen secondary metabolites in Flavocetraria cucullata Exhibit anti-cancer effects on human cancer cells through the induction of apoptosis and suppression of tumorigenic potentials

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Nguyen, Thanh Thi ^a,b   Yoon, Somy ^c   Yang, Yi ^a   Lee, Ho Bin ^a   Oh, Soonok ^a   Jeong, Min Hye ^a   Kim, Jong Jin ^a   Yee, Sung Tae ^a   Crişan, Florin ^d   Moon, Cheol ^a   Lee, Kwang Youl ^e   Kim, Kyung Keun ^c   Hur, Jae Seoun ^a   Kim, Hangun ^a  

^a Sunchon National University   (South Korea)

^b Tay Nguyen University   (Viet Nam)

^c Chonnam National University Medical School   (South Korea)

^d BABE BOLYAI UNIVERSITY   (Romania)

^e Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; ANTINEOPLASTIC AGENT; BAEOMYCESIC ACID; DEXTRO PROTOLICHESTERINIC ACID; FLAVOCETRARIA CUCULLATA EXTRACT; FUNGAL EXTRACT; LICHESTERINIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLANT MEDICINAL PRODUCT; PROTEIN KINASE B; SALAZINIC ACID; SQUAMATIC ACID; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; USNIC ACID; BENZOFURAN DERIVATIVE; LIPOCORTIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; FLAVOCETRARIA CUCULLATA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LICHEN (ORGANISM); LUNG CANCER; METABOLITE; MIGRATION INHIBITION; MOUSE; MTT ASSAY; NONHUMAN; OUTCOME ASSESSMENT; TUMOR VOLUME; ANIMAL; BAGG ALBINO MOUSE; CARCINOGENESIS; CELL ADHESION; CELL CYCLE G1 PHASE; CELL MOTION; CELL NUCLEUS; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; METABOLISM; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; SECONDARY METABOLISM; TUMOR CELL LINE;

FLAVOCETRARIA CUCULLATA;

ANIMALS; ANNEXIN A5; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOFURANS; CARCINOGENESIS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; G1 PHASE; HUMANS; LICHENS; MICE, INBRED BALB C; MICE, NUDE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SECONDARY METABOLISM;

EID: 84909992712     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0282452     Document Type: Erratum

References (30)

1. WHO (2013) World Health Statistics 2013.
2. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
3. Nash TH (2008) Lichen biology. Cambridge; New York: Cambridge University Press. ix, 486 p.
4. Fashelt D (1994) Secondary biochemistry of lichens. Symbiosis 16: 117-165.
5. Shrestha G, St. Clair LL (2013) Lichens: a promising source of antibiotic and anticancer drugs. Phytochem Rev 12: 229-244.
6. Kupchan SM, Kopperman HL (1975) l-usnic acid: tumor inhibitor isolated from lichens. Experientia 31: 625.
7. Takai M, Uehara Y, Beisler JA (1979) Usnic acid derivatives as potential antineoplastic agents. J Med Chem 22: 1380-1384.
8. Cardarelli M, Serino G, Campanella L, Ercole P, De Cicco Nardone F, et al. (1997) Antimitotic effects of usnic acid on different biological systems. Cell Mol Life Sci 53: 667-672.
9. Kumar KC, Muller K (1999) Lichen metabolites. 1. Inhibitory action against leukotriene B4 biosynthesis by a non-redox mechanism. J Nat Prod 62: 817-820.
10. Haraldsdottir S, Guolaugsdottir E, Ingolfsdottir K, Ogmundsdottir HM (2004) Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro. Planta Med 70: 1098-1100.
11. Russo A, Caggia S, Piovano M, Garbarino J, Cardile V (2012) Effect of vicanicin and protolichesterinic acid on human prostate cancer cells: role of Hsp70 protein. Chem Biol Interact 195: 1-10.
12. Ren MR, Hur JS, Kim JY, Park KW, Park SC, et al. (2009) Anti-proliferative effects of Lethariella zahlbruckneri extracts in human HT-29 human colon cancer cells. Food Chem Toxicol 47: 2157-2162.
13. Molnar K, Farkas E (2010) Current results on biological activities of lichen secondary metabolites: a review. Z Naturforsch C 65: 157-173.
14. Shukla V, Joshi GP, Rawat MSM (2010) Lichens as a potential natural source of bioactive compounds: a review. Phytochem Rev 9: 303-314.
15. Zambare VP, Christopher LP (2012) Biopharmaceutical potential of lichens. Pharm Biol 50: 778-798.
16. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1: 2315-2319.
17. Kim H, Ki H, Park HS, Kim K (2005) Presenilin-1 D257A and D385A mutants fail to cleave Notch in their endoproteolyzed forms, but only presenilin-1 D385A mutant can restore its gamma-secretase activity with the compensatory overexpression of normal C-terminal fragment. J Biol Chem 280: 22462-22472.
18. Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410: 37-40.
19. Fulton RJ, McDade RL, Smith PL, Kienker LJ, Kettman JR, Jr. (1997) Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 43: 1749-1756.
20. Gingrich JC, Davis DR, Nguyen Q (2000) Multiplex detection and quantitation of proteins on western blots using fluorescent probes. Biotechniques 29: 636-642.
21. Backor M, Pawlik-Skowronska B, Tomko J, Budova J, Sanita di Toppi L (2006) Response to copper stress in aposymbiotically grown lichen mycobiont Cladonia cristatella: uptake, viability, ergosterol and production of non-protein thiols. Mycol Res 110: 994-999.
22. Mayer M, O'Neill MA, Murray KE, Santos-Magalhaes NS, Carneiro-Leao AM, et al. (2005) Usnic acid: a non-genotoxic compound with anti-cancer properties. Anticancer Drugs 16: 805-809.
23. Backorova M, Jendzelovsky R, Kello M, Backor M, Mikes J, et al. (2012) Lichen secondary metabolites are responsible for induction of apoptosis in HT-29 and A2780 human cancer cell lines. Toxicol In Vitro 26: 462-468.
24. Singh N, Nambiar D, Kale RK, Singh RP (2013) Usnic acid inhibits growth and induces cell cycle arrest and apoptosis in human lung carcinoma A549 cells. Nutr Cancer 65 Suppl 1: 36-43.
25. Manojlovic N, Rankovic B, Kosanic M, Vasiljevic P, Stanojkovic T (2012) Chemical composition of three Parmelia lichens and antioxidant, antimicrobial and cytotoxic activities of some their major metabolites. Phytomedicine 19: 1166-1172.
26. Pavese JM, Farmer RL, Bergan RC (2010) Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev 29: 465-482.
27. Lecomte N, Njardarson JT, Nagorny P, Yang G, Downey R, et al. (2011) Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin. Proc Natl Acad Sci U S A 108: 15074-15078.
28. Wang J, Tan XF, Nguyen VS, Yang P, Zhou J, et al. (2014) A quantitative chemical proteomics approach to profile the specific cellular targets of andrographolide, a promising anticancer agent that suppresses tumor metastasis. Mol Cell Proteomics 13: 876-886.
29. Burlando B, Ranzato E, Volante A, Appendino G, Pollastro F, et al. (2009) Antiproliferative effects on tumour cells and promotion of keratinocyte wound healing by different lichen compounds. Planta Med 75: 607-613.
30. Song Y, Dai F, Zhai D, Dong Y, Zhang J, et al. (2012) Usnic acid inhibits breast tumor angiogenesis and growth by suppressing VEGFR2-mediated AKT and ERK1/2 signaling pathways. Angiogenesis 15: 421-432.